SCHEMBL8778939

SCHEMBL8778939

C=C1c2c(cccc2OCc2ccccc2)CCC12CCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RXRB P28702 5/20 0.38
RXRA P19793 4/20 0.38
RXRG P48443 3/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
KDM1A O60341 2/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
ALPG P10696 1/20 0.37
PTK2B Q14289 1/20 0.37
HTR1A P08908 2/20 0.36
DRD2 P14416 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778923 0.85 DRD2 (0.41) MAPTMAPK1TDP1L3MBTL1RXRB
SCHEMBL34466766 0.81 MAPT (0.45) MAPTMAPK1TDP1L3MBTL1RXRB
SCHEMBL8779163 0.80 HTT (0.46) MAPTMAPK1TDP1L3MBTL1RXRB
SCHEMBL8778973 0.73 MAOA (0.56) KDM1A
SCHEMBL8778979 0.73 MAOA (0.56) KDM1A
SCHEMBL7280823 0.71 MAOA (0.53) MAPTMAPK1TDP1L3MBTL1RXRB
SCHEMBL16844582 0.71 MAPT (0.49) MAPTMAPK1TDP1L3MBTL1RXRB
SCHEMBL8779076 0.70 PNMT (0.34)
SCHEMBL8216313 0.70 MAPT (0.69) MAPTMAPK1TDP1L3MBTL1KDM1A
SCHEMBL8779044 0.69 HTT (0.52) MAPTTDP1L3MBTL1RXRBRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed